Your browser doesn't support javascript.
loading
Iron deficiency is highly prevalent among candidates for metabolic surgery and may affect perioperative outcomes.
Benotti, Peter N; Wood, Gerald Craig; Dove, James T; Kaberi-Otarod, Jila; Still, Christopher D; Gerhard, Glenn S; Bistrian, Bruce R.
Afiliação
  • Benotti PN; Geisinger Obesity Institute, Danville, Pennsylvania. Electronic address: pbenotti64@gmail.com.
  • Wood GC; Geisinger Obesity Institute, Danville, Pennsylvania.
  • Dove JT; Geisinger Obesity Institute, Danville, Pennsylvania.
  • Kaberi-Otarod J; Geisinger Obesity Institute, Danville, Pennsylvania.
  • Still CD; Geisinger Obesity Institute, Danville, Pennsylvania.
  • Gerhard GS; Department of Medical Genetics and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
  • Bistrian BR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston. Massachusetts.
Surg Obes Relat Dis ; 17(10): 1692-1699, 2021 10.
Article em En | MEDLINE | ID: mdl-34266778
BACKGROUND: The presence of chronic low-grade inflammation, commonly identified in patients with severe obesity, alters iron homeostasis and indicators of iron status, fostering the development of updated guidelines for the diagnosis of iron deficiency (ID). Current recommended diagnostic thresholds for ID in obesity derived from expert opinion include a ferritin level of <30 ng/mL and/or transferrin saturation (TSAT) < 20%. Earlier studies of ID among candidates for metabolic surgery using low levels of ferritin or iron as diagnostic thresholds demonstrated a prevalence of 5%-20%. OBJECTIVES: Using the current recommended diagnostic thresholds for ID, this study measures the prevalence of ID in a large cohort of surgical candidates and its relationship to surgical outcomes. SETTING: Geisinger Medical Center, Danville, Pennsylvania. METHODS: The study cohort included 3,723 patients who underwent pre- operative nutritional assessment which included markers of iron nutrition over the period 2004-2018. RESULTS: The cohort included 2,988 women (80.3%) and 735 men (19.7%); body mass index: 49.4 ± 9 kg/m2. The diagnosis of ID was based on ferritin level <30 ng/mL (true ID) and/or TSAT < 20% representing a combination of true ID and inflammation (serum ferritin ≥ 30 ng/mL and TSAT < 20%). A total of 399 patients (10.8%) were anemic. A serum ferritin level of < 30 ng/mL was found in 488 patients (13%; 481 women and 7 men). Of these, 122 patients (25.2%) were also anemic. An additional 1,204 had serum ferritin ≥ 30 ng/mL and TSAT < 20%. Overall, 1,692 patients (45.4%) in this cohort had laboratory evidence of ID by current criteria that adjusts for the very high prevalence of inflammation. Men with serum ferritin levels ≥30 ng/mL with TSAT < 20% had an increased surgical length of stay. CONCLUSION: The prevalence of ID among surgical candidates (45.4%) is more than twice that identified as ID in earlier studies. ID was commonly identified in the absence of anemia. The most severe ID was found in those with a serum ferritin level <30 ng/mL and TSAT < 20%. ID in the presence of inflammation is often unrecognized and has implications regarding surgical outcomes after metabolic surgery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Ferropriva / Cirurgia Bariátrica / Anemia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Ferropriva / Cirurgia Bariátrica / Anemia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article